参考文献/References:
[1] Kirchhof P,Camm AJ,Goette A,et al. Early rhythm-control therapy in patients with atrial fibrillation[J]. N Engl J Med,2020,383(14):1305-1316.
[2] Zhang YY,Qiu C,Davis PJ,et al. Predictors of progression of recently diagnosed atrial fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation(RecordAF)-United States cohort[J]. Am J Cardiol,2013,112(1):79-84.
[3] Hindricks G,Potpara T,Dagres N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery(EACTS)[J]. Eur Heart J,2021,42(5):373-498.
[4] Hernández-Madrid A,Svendsen JH,Lip GY,et al. Cardioversion for atrial fibrillation in current European practice:results of the European Heart Rhythm Association survey[J]. Europace,2013,15(6):915-918.
[5] Pisters R,Nieuwlaat R,Prins MH,et al. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation:the Euro Heart Survey[J]. Europace,2012,14(5):666-674.
[6] Müssigbrodt A,John S,Kosiuk J,et al. Vernakalant-facilitated electrical cardioversion:comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion[J]. Europace,2016,18(1):51-56.
[7] Neumann T,Erdogan A,Reiner C,et al. Ambulatory electrocardioversion of atrial fibrillation by means of biphasic versus monophasic shock delivery. A prospective randomized study[J]. Z Kardiol,2004,93(5):381-387.
[8] Mittal S,Ayati S,Stein KM,et al. Transthoracic cardioversion of atrial fibrillation:comparison of rectilinear biphasic versus damped sine wave monophasic shocks[J]. Circulation,2000,101(11):1282-1287.
[9] Alatawi F,Gurevitz O,White RD,et al. Prospective,randomized comparison of two biphasic waveforms for the efficacy and safety of transthoracic biphasic cardioversion of atrial fibrillation[J]. Heart Rhythm,2005,2(4):382-387.
[10] Schmidt AS,Lauridsen KG,Adelborg K,et al. Cardioversion efficacy using pulsed biphasic or biphasic truncated exponential waveforms:a randomized clinical trial[J]. J Am Heart Assoc,2017,6(3):e004853.
[11] Deakin CD,Connelly S,Wharton R,et al. A comparison of rectilinear and truncated exponential biphasic waveforms in elective cardioversion of atrial fibrillation:a prospective randomized controlled trial[J]. Resuscitation,2013,84(3):286-291.
[12] Inácio JF,da Rosa Mdos S,Shah J,et al. Monophasic and biphasic shock for transthoracic conversion of atrial fibrillation:systematic review and network meta-analysis[J]. Resuscitation,2016,100:66-75.
[13] Lavignasse D,Trendafilova E,Dimitrova E,et al. Cardioversion of atrial fibrillation and flutter:comparative study of pulsed vs. low energy biphasic truncated exponential waveforms[J]. J Atr Fibrillation,2019,12(3):2172.
[14] Boos C,Thomas MD,Jones A,et al. Higher energy monophasic DC cardioversion for persistent atrial fibrillation:is it time to start at 360 joules?[J]. Ann Noninvasive Electrocardiol,2003,8(2):121-126.
[15] Boodhoo L,Mitchell AR,Bordoli G,et al. DC cardioversion of persistent atrial fibrillation:a comparison of two protocols[J]. Int J Cardiol,2007,114(1):16-21.
[16] Schmidt AS,Lauridsen KG,Torp P,et al. Maximum-fixed energy shocks for cardioverting atrial fibrillation[J]. Eur Heart J,2020,41(5):626-631.
[17] Alp NJ,Rahman S,Bell JA,et al. Randomised comparison of antero-lateral versus antero-posterior paddle positions for DC cardioversion of persistent atrial fibrillation[J]. Int J Cardiol,2000,75(2-3):211-216.
[18] Kirchhof P,Eckardt L,Loh P,et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation:a randomised trial[J]. Lancet,2002,360(9342):1275-1279.
[19] Siaplaouras S,Buob A,R?tter C,et al. Randomized comparison of anterolateral versus anteroposterior electrode position for biphasic external cardioversion of atrial fibrillation[J]. Am Heart J,2005,150(1):150-152.
[20] Zhang B,Li X,Shen D,et al. Anterior-posterior versus anterior-lateral electrode position for external electrical cardioversion of atrial fibrillation:a meta-analysis of randomized controlled trials[J]. Arch Cardiovasc Dis,2014,107(5):280-290.
[21] Chen CJ,Guo GB. External cardioversion in patients with persistent atrial fibrillation:a reappraisal of the effects of electrode pad position and transthoracic impedance on cardioversion success[J]. Jpn Heart J,2003,44(6):921-932.
[22] Ramirez FD,Fiset SL,Cleland MJ,et al. Effect of applying force to self-adhesive electrodes on transthoracic impedance:implications for electrical cardioversion[J]. Pacing Clin Electrophysiol,2016,39(10):1141-1147.
[23] Sadek MM,Chaugai V,Cleland MJ,et al. Association between transthoracic impedance and electrical cardioversion success with biphasic defibrillators:an analysis of 1 055 shocks for atrial fibrillation and flutter[J]. Clin Cardiol,2018,41(5):666-670.
[24] Voskoboinik A,Moskovitch J,Plunkett G,et al. Cardioversion of atrial fibrillation in obese patients:results from the cardioversion-BMI randomized controlled trial[J]. J Cardiovasc Electrophysiol,2019,30(2):155-161.
[25] Ramirez FD,Sadek MM,Boileau I,et al. Evaluation of a novel cardioversion intervention for atrial fibrillation:the Ottawa AF cardioversion protocol[J]. Europace,2019,21(5):708-715.
[26] Squara F,Elbaum C,Garret G,et al. Active compression versus standard anterior-posterior defibrillation for external cardioversion of atrial fibrillation. A prospective randomized study[J]. Heart Rhythm,2021,18(3):360-365.
[27] Gardner MW,Yadava M,Raitt MH,et al. Effectiveness of dual external direct current cardioversion for initial cardioversion in atrial fibrillation[J]. J Cardiovasc Electrophysiol,2019,30(9):1636-1643.
[28] Saliba W,Juratli N,Chung MK,et al. Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation[J]. J Am Coll Cardiol,1999,34(7):2031-2034.
[29] Bjerregaard P,El-Shafei A,Janosik DL,et al. Double external direct-current shocks for refractory atrial fibrillation[J]. Am J Cardiol,1999,83(6):972-974.
[30] Kabukcu M,Demircioglu F,Yanik E,et al. Simultaneous double external DC shock technique for refractory atrial fibrillation in concomitant heart disease[J]. Jpn Heart J,2004,45(6):929-936.
[31] Chang AK,Lent GS,Grinberg D. Double-dose external cardioversion for refractory unstable atrial fibrillation in the ED[J]. Am J Emerg Med,2008,26(3):381-383.
[32] Alaeddini J,Feng Z,Feghali G,et al. Repeated dual external direct cardioversions using two simultaneous 360-J shocks for refractory atrial fibrillation are safe and effective[J]. Pacing Clin Electrophysiol,2005,28(1):3-7.
[33] Toso E,Iannaccone M,Caponi D,et al. Does antiarrhythmic drugs premedication improve electrical cardioversion success in persistent atrial fibrillation?[J]. J Electrocardiol,2017,50(3):294-300.
[34] Bianconi L,Mennuni M,Lukic V,et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation:a placebo-controlled study[J]. J Am Coll Cardiol,1996,28(3):700-706.
[35] Climent VE,Marin F,Mainar L,et al. Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation[J]. Pacing Clin Electrophysiol,2004,27(3):368-372.
[36] Oral H,Souza JJ,Michaud GF,et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment[J]. N Engl J Med,1999,340(24):1849-1854.
[37] Simon A,Niederdoeckl J,Janata K,et al. Vernakalant and electrical cardioversion for AF—Safe and effective[J]. Int J Cardiol Heart Vasc,2019,24:100398.
[38] Singh SN,Tang XC,Reda D,et al. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs:a substudy of the SAFE-T trial[J]. Heart Rhythm,2009,6(2):152-155.
[39] Crijns HJ,Weijs B,Fairley AM,et al. Contemporary real life cardioversion of atrial fibrillation:results from the multinational RHYTHM-AF study[J]. Int J Cardiol,2014,172(3):588-594.
[40] Um KJ,McIntyre WF,Healey JS,et al. Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation:a systematic review and meta-analysis[J]. Europace,2019,21(6):856-863.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(8):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(8):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(8):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(8):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(8):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11].心房颤动体外直流电复律方案的研究进展[J].心血管病学进展,2021,(9):804.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
CHEN Qingsong,CHEN Yunlin,XIAO Mingyang,et al.External Direct Current Cardioversion for Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(8):804.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]